GlycoMimetics, Inc.
GALECTIN-3 INHIBITING C-GLYCOSIDES
Last updated:
Abstract:
Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of galectin-3 to ligands are disclosed. For example, inhibitors of galectin-3 are described and pharmaceutical compositions comprising at least one such agent is described.
Status:
Application
Type:
Utility
Filling date:
26 Dec 2019
Issue date:
10 Mar 2022